PN-23114

N/A

Report date: 2025/06/11 10:36:17
NME

Base Information

Drug NamePN-23114
Drug Alias NameN/A
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionHepcidin stimulants
TargetsHepcidin
Therapy Area/IndicationsHemochromatosisAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProtagonist Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesProtagonist Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemochromatosisAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A